Grifols (MEX:GRFP N) ROCE %: 5.56% (As of Mar. 2026)


MEX:GRFP N Grifols SA MEX:GRFP N
83 GF Score
Price MXN126.63
GF Value MXN154.24
! 6 Warning Signs
View Full Analysis

What is Grifols ROCE %?

Grifols MEX:GRFP N 83 ROCE % is 5.56% as of Mar. 2026. GuruFocus rates MEX:GRFP N with a GF Score™ of 83/100 and a GF Value™ of MXN154.24. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Grifols's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.56%.

Grifols  (MEX:GRFP N) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Grifols ROCE % Related Terms

Grifols ROCE % Historical Data

* Premium members only.

The historical data trend for Grifols's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grifols ROCE % Chart

Grifols Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.85 4.24 3.60 5.97 6.33

Grifols Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.77 7.47 7.95 4.90 5.56
MEX:GRFP N
83GF Score
Grifols SA MEX:GRFP N
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grifols ROCE % Calculation

Grifols's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=25110.994/( ( (467451.58 - 47083.654) + (415606.977 - 42568.511) )/ 2 )
=25110.994/( (420367.926+373038.466)/ 2 )
=25110.994/396703.196
=6.33 %

Grifols's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=20763.664/( ( (415606.977 - 42568.511) + (418567.111 - 44279.138) )/ 2 )
=20763.664/( ( 373038.466 + 374287.973 )/ 2 )
=20763.664/373663.2195
=5.56 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.56% mean?
Grifols (MEX:GRFP N) has a ROCE % of 5.56% as of Mar. 2026.
Is Grifols' ROCE % too high?
Grifols' current ROCE % is 5.56%. The Drug Manufacturers industry median ROCE % is 7.00. Grifols' value of 5.56% is 20.5% below this industry median. Overall, Grifols has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Grifols' ROCE % compare to LLY and JNJ?
Grifols' ROCE % of 5.56% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Grifols' value of 5.56% is 20.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grifols's current ROCE % of 5.56% is 20.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grifols's current ROCE % is 5.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grifols stock overvalued right now?
Grifols (MEX:GRFP N) has a current ROCE % of 5.56%. The stock's GF Value™ is MXN154.24, compared to a current price of MXN126.63 — trading 17.9% below its estimated fair value. The current ROCE % is 5.56% and 20.5% below the Drug Manufacturers industry median of 7.00. Grifols' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Grifols (MEX:GRFP N), the current ROCE % is 5.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grifols (MEX:GRFP N) Overvalued in 2026?

Based on GuruFocus' analysis, Grifols stock appears to be undervalued. The current stock price of MXN126.63 is trading 17.9% below its estimated GF Value™ of MXN154.24.

Key valuation signals for MEX:GRFP N:

  • ROCE %: 5.56%
  • GF Value™: MXN154.24 vs. price of MXN126.63 (17.9% below fair value)
  • GF Score™: 83/100 with 6 warning signs
  • Industry Position: 20.5% below the Drug Manufacturers median

No single metric tells the full story. See the MEX:GRFP N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grifols Business Description

Address Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
83GF Score

Get the complete analysis for MEX:GRFP N

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN126.63
Price
MXN154.24
GF Value